View allAll Photos Tagged MedTech
Conor Hale
Senior Editor, Fierce Medtech
Theresa LaVallee
Chief Development Officer, Coherus BioSciences
Joni Rutter
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Laurence Sperling
Chief Medical Officer, Family Heart Foundation
Peter Stein
Director, Office of New Drugs, US Food and Drug Administration
Governor Charlie Baker visits the MedTech Conference at BCEC in Boston on Oct. 24 2022. The annual two-day conference showcases about 1,000 global manufacturers and innovators in medical devices, diagnostic products and digital health technologies. [Joshua Qualls/Governor’s Press Office]
We hosted The Duke Of York as he and his team toured the #VicInnovationHub and met with LaunchVic, Medtech Actuator, Stone and Chalk, SproutX_ and Startmate plus startup residents.
Conor Hale
Senior Editor, Fierce Medtech
Theresa LaVallee
Chief Development Officer, Coherus BioSciences
Joni Rutter
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Laurence Sperling
Chief Medical Officer, Family Heart Foundation
Peter Stein
Director, Office of New Drugs, US Food and Drug Administration
MedTech Edge is the leading provider medical devices company in Australia. At here, we provide the NONINVASIVE Peripheral Vascular Examination or test & diagnosis that will exceed your imagination.
Conor Hale
Senior Editor, Fierce Medtech
Theresa LaVallee
Chief Development Officer, Coherus BioSciences
Joni Rutter
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Laurence Sperling
Chief Medical Officer, Family Heart Foundation
Peter Stein
Director, Office of New Drugs, US Food and Drug Administration
Conor Hale
Senior Editor, Fierce Medtech
Theresa LaVallee
Chief Development Officer, Coherus BioSciences
Joni Rutter
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Laurence Sperling
Chief Medical Officer, Family Heart Foundation
Peter Stein
Director, Office of New Drugs, US Food and Drug Administration